Ping Chen
10Patents
2h-index
18Co-inventors
51Inventor score
Filing activity: Jul 28, 2000 → Sep 9, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6342385B1 | Mutacin I biosynthesis genes and proteins | Human Necessities | 5 | Expired |
| US6699970B2 | Mutacin I biosynthesis genes and proteins | Human Necessities | 3 | Expired |
| US6902746B2 | Oral pharmaceutical compositions containing non-steroidal anti-inflammatory drugs and method for preparing the same | Human Necessities | 1 | Expired |
| US10301609B2 | Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin | Chemistry; Metallurgy | 1 | Active |
| US11473069B2 | Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin | Chemistry; Metallurgy | 1 | Active |
| US6673373B2 | Antifungal formulation and the methods for manufacturing and using the same | Human Necessities | 1 | Expired |
| US12336978B2 | Pharmaceutical composition containing amlodipine, chlorthalidone, and amiloride and application thereof | Human Necessities | 0 | Active |
| US7655236B2 | Lanthionine antibiotic compositions and methods | Human Necessities | 0 | Active |
| US12116602B2 | Butyrylcholinesterases having an enhanced ability to hydrolyze acyl ghrelin | Chemistry; Metallurgy | 0 | Active |
| US11865163B2 | Methods and materials for using butyrylcholinesterases to treat cancer | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.